Vanguard Group Inc Ocugen, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 16,949,019 shares of OCGN stock, worth $13.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,949,019
Previous 15,521,167
9.2%
Holding current value
$13.1 Million
Previous $24.1 Million
30.25%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding OCGN
# of Institutions
124Shares Held
78.3MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$13.8 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$12.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$4.83 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.89 Million0.1% of portfolio
-
Altium Capital Management LP New York, NY2.35MShares$1.81 Million0.82% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $167M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...